Fortis Healthcare Limited has issued a comprehensive postal ballot notice to shareholders seeking approval for the appointment of Mr. Mohd Shahazwan Bin Mohd Harris as Non-Independent Non-Executive Director. The healthcare company communicated these developments to stock exchanges under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015 on December 23, 2025.

Director Appointment and Board Changes

The Board of Directors approved the appointment of Mr. Mohd Shahazwan Bin Mohd Harris as Additional Director (Non-Executive Non-Independent) through a circular resolution passed on December 19, 2025. This appointment follows the resignation of Mr. Lim Tsin Lin from his position as Non-Executive Non-Independent Director, effective from the close of business hours on December 19, 2025.

Postal Ballot Notice and Voting Process

Fortis Healthcare issued the postal ballot notice on December 23, 2025, seeking member approval for appointing Mr. Mohd Shahazwan Bin Mohd Harris as a Non-Independent Non-Executive Director, liable to retire by rotation. This complies with SEBI Listing Regulations requirement for shareholder approval within three months of director appointment.

Professional Background and Qualifications

Mr. Shahazwan brings extensive experience to the Board, with over 25 years in investments, mergers and acquisitions, portfolio and asset management, corporate strategy, and restructuring. He currently serves as Advisor, Special Projects in UEM Group and was appointed to the Board of IHH Healthcare Berhad in March 2023.

His career highlights include serving as Head, Strategic Investments at Employees Provident Fund (EPF), Chief International Officer at Tenaga Nasional Berhad (TNB), and various investment roles at Khazanah Nasional Berhad from 2005 to 2016, covering investments across Asia and Europe.

Nomination and Compliance Details

The company received a nomination letter dated December 10, 2025, from Northern TKV Venture Pte. Limited, nominating Mr. Shahazwan for the director position. The appointment complies with Companies Act 2013 provisions and SEBI regulations, with the company confirming that Mr. Shahazwan is not debarred from holding the office of Director by any regulatory authorities.

Voting Instructions and E-voting Facility

The company is offering comprehensive e-voting facility through KFintech platform, enabling members to vote electronically instead of physical postal ballot forms. Members holding shares as of the cut-off date December 19, 2025, are eligible to participate in the voting process through multiple access methods including NSDL, CDSL, and direct KFintech platforms.

The voting process complies with Companies Act 2013 provisions and SEBI regulations, with detailed instructions provided for both demat and physical shareholders. Results will be declared at the Corporate Office and displayed on the company website and stock exchanges, with the resolution deemed passed if requisite majority assents to the proposal.

Fortis Healthcare has secured a favorable ruling from the Delhi High Court in a civil suit filed against a third party and others. The court's order dated December 19, 2025, decided the case in favor of the company, granting permanent injunction against the third party's actions and upholding the company's challenge to their locus.

Background of the Legal Dispute

The legal proceedings stem from events that occurred in the year ended March 31, 2023. A party claiming to be an assignee of a third party initiated arbitration proceedings against Fortis Healthcare. During these proceedings, an ex-parte interim award was passed, which was subsequently terminated by the arbitrator.

The company disclosed that it neither received any notice nor any statement of claim regarding the arbitration proceedings. In response to these developments, Fortis Healthcare filed a civil suit challenging the locus of the said parties and seeking permanent injunction against their actions.

Court Ruling Details

The following table summarizes the key aspects of the legal settlement:

Financial Impact Assessment

Fortis Healthcare has confirmed that the settlement will have no impact on the company's financial position. The company stated that no compensation or penalty was paid as part of this resolution, and the terms of settlement are not applicable given the nature of the court's ruling in their favor.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company formally notified the stock exchanges on December 23, 2025, at 12:33 p.m., ensuring compliance with regulatory requirements for material event disclosures.

This legal victory provides clarity on the disputed matter and removes any potential uncertainty that may have surrounded the arbitration proceedings initiated against the company.